Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Merit Medical Sys (NQ: MMSI )

103.66 -0.34 (-0.33%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Merit Medical Sys

< Previous 1 2 3 Next >
3 Top Healthcare Stocks to Buy for July
Three medical device stocks that make solid long-term investments. 
Via The Motley Fool
Merit Medical's Recent M&A Efforts Set To Show Early Impact In FY24: Analyst Insight
Barrington Research analyst Michael Petusky reiterated an Outperform rating on Merit Medical Systems, Inc. (NASDAQ: MMSI), with a  
Via Benzinga
The Latest Analyst Ratings for Merit Medical Systems
Via Benzinga
Future Of Merit Medical Systems: Analyst Predictions On Revenue Growth And Operating Margin Improvement
Needham analyst Mike Matson reiterated a Buy rating on the shares of Merit Medical Systems, Inc. (NASDAQ: MMSI),  
Via Benzinga
AngioDynamics Divests Dialysis Portfolio And Biopsy Product Line To Merit Medical Systems For $100M
AngioDynamics, Inc. (NASDAQ: ANGO)  
Via Benzinga
Where Merit Medical Systems Stands With Analysts
Via Benzinga
Analyst Ratings for Merit Medical Systems
Via Benzinga
Merit Medical To See Sustained Revenue Growth Despite Macro Headwinds, Bullish Analyst Says
Via Benzinga
Analyst Ratings for Merit Medical Systems
Via Benzinga
Earnings Scheduled For October 28, 2021
Companies Reporting Before The Bell • LendingTree (NASDAQ:TREE) is estimated to report quarterly earnings at $0.57 per share on revenue of $292.63 million. •... 
Via Benzinga
Top 5 Health Care Stocks That Should Keep You Up At Night
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. 
Via Benzinga
Chart Of The Day: Merit Medical Systems - Strong Buy Sentiment
Revenue is predicted to grow 6.20% this year and another 5.30% next year. Earnings are estimated to increase by 7.40% this year, and an additional 10.00% next year. 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For December 20, 2022
Via Benzinga
Earnings Scheduled For February 22, 2023
Companies Reporting Before The Bell • Rio Tinto (NYSE:RIO) is projected to report earnings for its Fiscal Year 2022. 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  During Thursday's session, 108 stocks hit new 52-week highs. 
Via Benzinga
Lantheus Holdings Stock Showing Market Leadership; Earns 94 RS Rating
Lantheus Holdings stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, rising from 90 to 94. 
Via Investor's Business Daily
Merit Medical Systems: Q3 Earnings Insights
Merit Medical Systems (NASDAQ:MMSI) reported its Q3 earnings results on Wednesday, October 26, 2022 at 04:05 PM. Here's what investors need to know about the announcement. 
Via Benzinga
A Preview Of Merit Medical Systems's Earnings
Merit Medical Systems (NASDAQ:MMSI) is set to give its latest quarterly earnings report on Wednesday, 2022-10-26. Here's what investors need to know before the announcement. Analysts estimate that... 
Via Benzinga
Recap: Merit Medical Systems Q2 Earnings
Merit Medical Systems (NASDAQ:MMSI) reported its Q2 earnings results on Wednesday, July 27, 2022 at 04:05 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Merit Medical Bullish On FY23 Operating Margin Of 18-21%, Needham Says Could Exceed
At the Annual Needham Healthcare Conference, Merit Medical Systems Inc's (NASDAQ: MMSI) management said that inflationary pressures and supply chain issues have been manageable and have not had a... 
Via Benzinga
Merger Arbitrage Mondays - Google (GOOG) Acquires Cybersecurity Firm Mandiant (MNDT)
Merger activity declined last week with three new deals announced and five deals completed. Two of the three new deals announced were potential deals in the works. I was surprised... 
Via Benzinga
Medical Device Maker Merit Medical Mulls Sale: Reuters
Merit Medical Systems Inc (NASDAQ: MMSI) is exploring options that include an outright sale to a private equity firm, Reuters reported citing people familiar with the... 
Via Benzinga
Recap: Merit Medical Systems Q4 Earnings
Merit Medical Systems (NASDAQ:MMSI) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:05 PM. Here's what investors need to know about the announcement.... 
Via Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David Hering As Interim CEO Adagio Therapeutics, Inc., (... 
Via Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front... 
Via Benzinga
Merit Medical Systems Inc (MMSI) Q3 2021 Earnings Call Transcript
MMSI earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Corvus' China Partner Approved For Early Stage Study Of CPI-818 In... 
Via Benzinga
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength... 
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:... 
Via Benzinga
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) AbbVie Inc. (NASDAQ: ABBV... 
Via Benzinga
Exposures COVID-19 Product Safety
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.